Literature DB >> 30343316

Beat around the bush for VA-LRTI.

Ignacio Martin-Loeches1,2,3, Pieter Depuydt4, Michael S Niederman5.   

Abstract

Mesh：

Year:  2018        PMID： 30343316     DOI： 10.1007/s00134-018-5281-y

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  8 in total

1.  Long-term impact of a multifaceted prevention program on ventilator-associated pneumonia in a medical intensive care unit.

Authors:  Lila Bouadma; Emmanuelle Deslandes; Isabelle Lolom; Bertrand Le Corre; Bruno Mourvillier; Bernard Regnier; Raphael Porcher; Michel Wolff; Jean-Christophe Lucet
Journal:  Clin Infect Dis       Date:  2010-10-11       Impact factor: 9.079

2.  Incidence and prognosis of ventilator-associated tracheobronchitis (TAVeM): a multicentre, prospective, observational study.

Authors:  Ignacio Martin-Loeches; Pedro Povoa; Alejandro Rodríguez; Daniel Curcio; David Suarez; Jean-Paul Mira; Maria Lourdes Cordero; Raphaël Lepecq; Christophe Girault; Carlos Candeias; Philippe Seguin; Carolina Paulino; Jonathan Messika; Alejandro G Castro; Jordi Valles; Luis Coelho; Ligia Rabello; Thiago Lisboa; Daniel Collins; Antonio Torres; Jorge Salluh; Saad Nseir
Journal:  Lancet Respir Med       Date:  2015-10-22       Impact factor: 30.700

3.  International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT).

Authors:  Antoni Torres; Michael S Niederman; Jean Chastre; Santiago Ewig; Patricia Fernandez-Vandellos; Hakan Hanberger; Marin Kollef; Gianluigi Li Bassi; Carlos M Luna; Ignacio Martin-Loeches; J Artur Paiva; Robert C Read; David Rigau; Jean François Timsit; Tobias Welte; Richard Wunderink
Journal:  Eur Respir J       Date:  2017-09-10       Impact factor: 16.671

Review 4.  Reappraisal of routine oral care with chlorhexidine gluconate for patients receiving mechanical ventilation: systematic review and meta-analysis.

Authors:  Michael Klompas; Kathleen Speck; Michael D Howell; Linda R Greene; Sean M Berenholtz
Journal:  JAMA Intern Med       Date:  2014-05       Impact factor: 21.873

Review 5.  Selective digestive or oropharyngeal decontamination and topical oropharyngeal chlorhexidine for prevention of death in general intensive care: systematic review and network meta-analysis.

Authors:  Richard Price; Graeme MacLennan; John Glen
Journal:  BMJ       Date:  2014-03-31

6.  Prevention of Ventilator-Associated Pneumonia: The Multimodal Approach of the Spanish ICU "Pneumonia Zero" Program.

Authors:  Francisco Álvarez-Lerma; Mercedes Palomar-Martínez; Miguel Sánchez-García; Montserrat Martínez-Alonso; Joaquín Álvarez-Rodríguez; Leonardo Lorente; Susana Arias-Rivera; Rosa García; Federico Gordo; José M Añón; Rosa Jam-Gatell; Mónica Vázquez-Calatayud; Yolanda Agra
Journal:  Crit Care Med       Date:  2018-02       Impact factor: 7.598

7.  Effects of chlorhexidine gluconate oral care on hospital mortality: a hospital-wide, observational cohort study.

Authors:  Mieke Deschepper; Willem Waegeman; Kristof Eeckloo; Dirk Vogelaers; Stijn Blot
Journal:  Intensive Care Med       Date:  2018-05-09       Impact factor: 17.440

8.  Impact of a multifaceted prevention program on ventilator-associated pneumonia including selective oropharyngeal decontamination.

Authors:  C Landelle; V Nocquet Boyer; M Abbas; E Genevois; N Abidi; S Naimo; R Raulais; L Bouchoud; F Boroli; H Terrisse; J-L Bosson; S Harbarth; J Pugin
Journal:  Intensive Care Med       Date:  2018-10-21       Impact factor: 17.440
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.